phenylephrine-hydrochloride and Lymphoma

Topics: Humans; Lymphoma; Neck; Nose; Otolaryngology; Pharynx; Thoracic Wall

Published studies describing outcomes for cats with nasal lymphoma (NLSA) receiving first-line palliative radiation (PRT) versus PRT after chemotherapy failure are currently lacking. The aims of this retrospective observational study were to compare outcomes for cats with NLSA that were treated with these two methods. A total of 48 cats were included in analyses; 32 receiving PRT alone and 16 receiving PRT after chemotherapy failure. The treatment response, progression-free survival (PFS), disease-specific survival (DSS), overall survival (OS), and incidence rate of systemic disease were compared between the two groups. The overall response rate (ORR) was calculated from the same target lesions between pre-RT (within a week before starting PRT) and post-RT (on date of PRT completion) by computed tomography (CT) imaging. The ORR was 94% in cats that received PRT alone, 13 had a complete response (CR) and 17 had a partial response (PR). The ORR was 88% in cats that received PRT after chemotherapy failure, with five having CR and nine with PR. There were no significant differences in the ORR between the two groups. The PFS, DSS, and OS significantly increased in the cats that received PRT alone compared to the cats that received PRT after chemotherapy failure (median PFS: 336 vs 228 days, P = 0.0012, median DSS: 360 vs 242 days, P = 0.0025, median OS: 346 vs 242 days, P = 0.0036, respectively). The incidence rate of systemic disease significantly increased in 75% (12/16) of cats receiving PRT after chemotherapy failure compared to 41% (13/32) of cats receiving PRT alone. The results suggested that clinical outcomes may improve in cats with NLSA with first-line PRT compared to PRT after chemotherapy failure.

Topics: Animals; Cat Diseases; Cats; Lymphoma; Nose; Nose Neoplasms; Retrospective Studies

Topics: Adult; Humans; Lymphoma; Male; Mouth; Myiasis; Nose

Topics: Antigens, CD20; Biopsy; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Nose; Polyradiculopathy; Vascular Neoplasms

Most hematolymphoid malignancies in the head and neck were malignant lymphomas that most often occurred in sexagenarian men. Approximately 80% of them were B-cell lymphomas with a predominance of diffuse large B-cell lymphoma (DLBCL) in both nodal and extranodal sites. Our results were compatible with those in a previous study that was conducted in the central part of Japan.. This analysis was performed to describe the anatomic distribution of hematolymphoid malignancies that were diagnosed by biopsy in our department.. Clinical medical records of 122 patients with hematolymphoid malignancies in the head and neck from January 2004 to December 2010 were retrospectively reviewed. The anatomic site of origin according to the histopathology of each malignancy was analyzed.. The incidence ratio of hematolymphoid malignancies was 15.1%. The male:female ratio was 2.3:1. Ages ranged from 17 to 89 years (median, 66). Of the 122 cases, 121 were lymphoid neoplasms (4 cases of Hodgkin lymphoma and 117 cases of non-Hodgkin lymphoma) and the remaining 1 was myeloid. The most common histopathology was DLBCL (54.9%), followed by follicular lymphoma (8.2%), and peripheral T-cell lymphoma (8.2%). Most commonly, the oropharynx (36.1%) and the cervical lymph node (34.4%) were affected.

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Head and Neck Neoplasms; Humans; Japan; Lymph Nodes; Lymphoma; Male; Middle Aged; Mouth; Neck; Nose; Pharynx; Retrospective Studies; Sarcoma, Myeloid; Young Adult

4 cases of malignant tumors of the head and neck diagnosed in our department in 1983-1987 are presented. They are: rhabdomyosarcoma (RMS) of the nose and the ethmoid sinuses, RMS of the nasal vestibulum, nasopharyngeal lymphoma malignum. Diagnostic difficulties were met by the histopathological evaluation of the tumors specimens, but the applied treatment was effective. There are no signs of recurrence during the observation period of 4-8 years.

Topics: Carcinoma, Adenoid Cystic; Child; Child, Preschool; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Nose; Nose Neoplasms; Pharynx; Rhabdomyosarcoma

Topics: Adult; Autopsy; Behcet Syndrome; Biopsy; Colitis, Ulcerative; Humans; Intestines; Lymphoma; Male; Nose; Nose Neoplasms

Topics: Acne Vulgaris; Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fibrosarcoma; Follow-Up Studies; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Nose; Skin Transplantation; Surgery, Plastic; Transplantation, Autologous

Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Nose; Nose Neoplasms

Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Nose; Sarcoma; Turbinates

Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Nose; Sarcoma; Turbinates

Topics: Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Nose; Sarcoma